Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease, Idiopathic”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00125567
What this trial is testing

Stalevo in Early Wearing-Off Patients

Who this might be right for
Idiopathic Parkinson's Disease
Orion Corporation, Orion Pharma 223
Not applicableStudy completedNCT05127057
What this trial is testing

Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)

Who this might be right for
Parkinsonism
University of Bristol 214
Early research (Phase 1)WithdrawnNCT05832775
What this trial is testing

Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's

Who this might be right for
Idiopathic Parkinson Disease
4D pharma plc
Not applicableNot Yet RecruitingNCT07622303
What this trial is testing

Depression, Anxiety and Sleep in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sohag University 100
Early research (Phase 1)Looking for participantsNCT07195825
What this trial is testing

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

Who this might be right for
PD
Shanghai Xinzhi BioMed Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03305809
What this trial is testing

LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

Who this might be right for
Lewy Body Dementia
Eli Lilly and Company 344
Testing effectiveness (Phase 2)Study completedNCT03652363
What this trial is testing

GDNF in ideopathicParkinsons Disease

Who this might be right for
Idiopathic Parkinson Disease
North Bristol NHS Trust 42
Not applicableNot Yet RecruitingNCT07838675
What this trial is testing

MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's Disease

Who this might be right for
Parkinson Disease, Idiopathic
Queen's University, Belfast 120
Testing effectiveness (Phase 2)Study completedNCT01221948
What this trial is testing

Vercise Implantable Stimulator for Treating Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Boston Scientific Corporation 53
Not applicableUnknownNCT02494908
What this trial is testing

Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Dr. Sharon Hassin 80
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Not applicableStudy completedNCT02248168
What this trial is testing

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 1,449
Large-scale testing (Phase 3)Study completedNCT01187966
What this trial is testing

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 669
Testing effectiveness (Phase 2)UnknownNCT00498758
What this trial is testing

The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Tel-Aviv Sourasky Medical Center 60
Not applicableStudy completedNCT02248181
What this trial is testing

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 442
Testing effectiveness (Phase 2)Active Not RecruitingNCT04459052
What this trial is testing

FDOPA PET and Nutritional Support in Parkinson's Disease

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Thomas Jefferson University 50
Post-approval studies (Phase 4)Ended earlyNCT03968744
What this trial is testing

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease (at Later Stage)
Alain Kaelin 11
Not applicableStudy completedNCT02231294
What this trial is testing

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 1,464
Testing effectiveness (Phase 2)Ended earlyNCT03720418
What this trial is testing

Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Sio Gene Therapies 6
Post-approval studies (Phase 4)Study completedNCT00141518
What this trial is testing

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Who this might be right for
Advanced Idiopathic Parkinson's Disease
AbbVie (prior sponsor, Abbott) 77
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation